Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 37

1.

Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection.

Regueiro M, Feagan BG, Zou B, Johanns J, Blank MA, Chevrier M, Plevy S, Popp J, Cornillie FJ, Lukas M, Danese S, Gionchetti P, Hanauer SB, Reinisch W, Sandborn WJ, Sorrentino D, Rutgeerts P; PREVENT Study Group.

Gastroenterology. 2016 Mar 3. pii: S0016-5085(16)00293-6. doi: 10.1053/j.gastro.2016.02.072. [Epub ahead of print]

2.

Preclinical and Undiagnosed Crohn's Disease: The Submerged Iceberg.

Sorrentino D.

Inflamm Bowel Dis. 2016 Feb;22(2):476-86. doi: 10.1097/MIB.0000000000000612.

PMID:
26752471
3.

Utility of Fecal Markers to Diagnose and Monitor Inflammatory Bowel Diseases.

Sorrentino D, Franck C.

Am J Gastroenterol. 2015 Dec;110(12):1732-3. doi: 10.1038/ajg.2015.366. No abstract available.

PMID:
26673502
4.

Low Dose Infliximab for Prevention of Postoperative Recurrence of Crohn's Disease: Long Term Follow-Up and Impact of Infliximab Trough Levels and Antibodies to Infliximab.

Sorrentino D, Marino M, Dassopoulos T, Zarifi D, Del Bianco T.

PLoS One. 2015 Dec 15;10(12):e0144900. doi: 10.1371/journal.pone.0144900. eCollection 2015.

5.

Cerebrovascular events in inflammatory bowel disease patients treated with anti-tumour necrosis factor alpha agents.

Karmiris K, Bossuyt P, Sorrentino D, Moreels T, Scarcelli A, Legido J, Dotan I, Naismith GD, Jussila A, Preiss JC, Kruis W, Li AC, Bouguen G, Yanai H, Steinwurz F, Katsanos KH, Subramaniam K, Tarabar D, Zaganas IV, Ben-Horin S; ECCO CONFER investigators.

J Crohns Colitis. 2015 May;9(5):382-9. doi: 10.1093/ecco-jcc/jjv042. Epub 2015 Mar 4.

PMID:
25740813
6.

A rare case of hyperproliferative gastropathy.

Sinagra E, Raimondo D, Pompei G, Sorrentino D.

Dig Liver Dis. 2015 Jan;47(1):85. doi: 10.1016/j.dld.2014.08.033. Epub 2014 Sep 16. No abstract available.

PMID:
25217225
7.

Long-term prevention of postoperative Crohn's disease recurrence with azathioprine: the wolf in the sheep clothing.

Robb PM, Sorrentino D.

Int J Colorectal Dis. 2015 Feb;30(2):283-4. doi: 10.1007/s00384-014-1984-x. Epub 2014 Aug 21. No abstract available.

PMID:
25139367
8.

Tissue studies in screened first-degree relatives reveal a distinct Crohn's disease phenotype.

Sorrentino D, Avellini C, Geraci M, Dassopoulos T, Zarifi D, Vadalaʼ di Prampero SF, Benevento G.

Inflamm Bowel Dis. 2014 Jun;20(6):1049-56. doi: 10.1097/MIB.0000000000000051.

PMID:
24788221
9.

Stopping anti-TNF agents in patients with Crohn's disease in remission: is it a feasible long-term strategy?

Sorrentino D, Nash P, Viladomiu M, Hontecillas R, Bassaganya-Riera J.

Inflamm Bowel Dis. 2014 Apr;20(4):757-66. doi: 10.1097/01.MIB.0000442680.47427.bf. Review. No abstract available.

PMID:
24572206
10.

Pre-clinical Crohn's disease: diagnosis, treatment and six year follow-up.

Sorrentino D, Avellini C, Geraci M, Vadalà S.

J Crohns Colitis. 2014 Jul;8(7):702-7. doi: 10.1016/j.crohns.2013.12.008. Epub 2014 Jan 8.

PMID:
24411923
11.

Translational research and efficacy of biologics in Crohn's disease: a cautionary tale.

Auer K, Trachter R, Van den Bogaerde J, Bassaganya-Riera J, Sorrentino D.

Expert Rev Clin Immunol. 2014 Feb;10(2):219-29. doi: 10.1586/1744666X.2014.877839. Review.

PMID:
24410538
12.

Infliximab vs adalimumab for Crohn's disease: perhaps too early to call it a tie.

Dassopoulos T, Sorrentino D.

Clin Gastroenterol Hepatol. 2014 May;12(5):818-20. doi: 10.1016/j.cgh.2013.12.006. Epub 2013 Dec 14. No abstract available.

PMID:
24342747
13.

Surgery for Crohn's disease and anti-TNF agents: the changing scenario.

Sorrentino D, Fogel S, Van den Bogaerde J.

Expert Rev Gastroenterol Hepatol. 2013 Nov;7(8):689-700. doi: 10.1586/17474124.2013.842895. Review.

PMID:
24161133
14.

State-of-the-art medical prevention of postoperative recurrence of Crohn's disease.

Sorrentino D.

Nat Rev Gastroenterol Hepatol. 2013 Jul;10(7):413-22. doi: 10.1038/nrgastro.2013.69. Epub 2013 May 7. Review.

PMID:
23648935
15.

The role of magnetic resonance imaging in detecting intestinal fibrosis in Crohn's disease.

Fiorino G, Cesarini M, Malesci A, Danese S, Sorrentino D.

Curr Drug Targets. 2012 Sep 1;13(10):1273-9.

PMID:
22664085
16.

Mucosal healing and clinical remission in inflammatory bowel diseases: are we missing something here?

Sorrentino D.

Inflamm Bowel Dis. 2013 Mar-Apr;19(4):E55-6. doi: 10.1002/ibd.22999. No abstract available.

PMID:
22517503
17.

Clinical remission after stopping infliximab in Crohn's disease: is all that glitters true gold?

Sorrentino D, Radford-Smith G.

Gastroenterology. 2012 May;142(5):e17; author reply e18. doi: 10.1053/j.gastro.2012.02.054. Epub 2012 Mar 24. No abstract available.

PMID:
22453047
18.

Anti-TNFs for prevention of postoperative recurrence of Crohn's disease: a broken record?

Sorrentino D.

Inflamm Bowel Dis. 2012 Sep;18(9):1624-5; author reply 1626-7. doi: 10.1002/ibd.22919. Epub 2012 Feb 22. No abstract available.

PMID:
22359378
19.

Recommendations for the treatment of ulcerative colitis with infliximab: a gastroenterology expert group consensus.

Reinisch W, Van Assche G, Befrits R, Connell W, D'Haens G, Ghosh S, Michetti P, Ochsenkühn T, Panaccione R, Schreiber S, Silverberg MS, Sorrentino D, van der Woude CJ, Vermeire S, Panes J.

J Crohns Colitis. 2012 Mar;6(2):248-58. doi: 10.1016/j.crohns.2011.11.001. Epub 2012 Jan 10.

20.

Early diagnosis and treatment of postoperative endoscopic recurrence of Crohn's disease: partial benefit by infliximab--a pilot study.

Sorrentino D, Terrosu G, Paviotti A, Geraci M, Avellini C, Zoli G, Fries W, Danese S, Occhipinti P, Croatto T, Zarifi D.

Dig Dis Sci. 2012 May;57(5):1341-8. doi: 10.1007/s10620-011-2025-z. Epub 2012 Jan 18.

PMID:
22252267
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk